1. US Food and Drug Administration. 2021. Potential for false results with Roche Molecular Systems Inc. cobas SARS-CoV-2 & Influenza Test for use on cobas Liat System-letter to clinical laboratory staff point-of-care facility staff and health care providers. https://www.fda.gov/medical-devices/letters-health-care-providers/potential-false-results-roche-molecular-systems-inc-cobas-sars-cov-2-influenza-test-use-cobas-liat.
2. Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study
3. Roche Diagnostics Corporation. 2021. cobas SARS-CoV-2 & Influenza A/B assay for use under emergency use authorization-potential for invalid or false positive results. Roche Diagnostics Corporation Indianapolis IN.
4. US Food and Drug Administration. 2020. Emergency use authorization. https://www.fda.gov/media/142190/download.